title: Dopaminergic contribution to the regulation of emotional perception.
abstract: Dopamine (DA) acts as a key neurotransmitter in the brain. Numerous studies have shown its regulatory role in motor and cognitive function. However, the impairment of emotional processes in neurologic and psychiatric pathologies involving the dopaminergic system (Parkinson disease, schizophrenia, autism, Attention Deficit Hyperactivity Disorder, Huntington disease, frontal lobe lesions), as well as the influence that administration of dopaminergic agonists/antagonists exert on the processing of emotion, suggest a role for DA in emotional processes. Moreover, emotional processes are dependent upon a variety of structures, the majority of which form part of the limbic system and are subject to DA innervation. In reviewing the literature, the amygdala emerges as a brain structure critical for emotional processing. It may also be implicated in deficits in emotional recognition found in two major disorders where DA's implication is clear: Parkinson disease and schizophrenia. In addition, the amygdala's response to emotional tasks is likely to be altered by the administration of both agonist and antagonist dopaminergic drugs. Experimental studies reinforce the idea of a dopaminergic contribution to emotional response, as suggested by biochemical, pharmacologic, and lesion experiments. Although the implication of the dopaminergic system in emotional processing appears to be clearly documented, the contribution of specific DA receptor subtypes, or of the DA cotransmitters cholecystokinin and neurotensin, or even glutamate, is, however, still unclear. Altogether, these observations suggest that DA has, undoubtedly, a direct and/or indirect role in the full emotional process.
authors.affiliation: Institut des Neurosciences Cognitives de la Méditerranée, Faculté de Médecine, UMR 6193CNRS Université de la Méditerranée, France.
authors.forename: Pilar
authors.initials: P
authors.lastname: Salgado-Pineda
authors.forename: Pauline
authors.initials: P
authors.lastname: Delaveau
authors.forename: Olivier
authors.initials: O
authors.lastname: Blin
authors.forename: André
authors.initials: A
authors.lastname: Nieoullon
mesh_terms: D000818:Animals; D001921:Brain / Q000033:anatomy & histology / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D004644:Emotions; D006801:Humans; D001523:Mental Disorders / Q000503:physiopathology / Q000523:psychology; D009415:Nerve Net / Q000502:physiology; D009422:Nervous System Diseases / Q000503:physiopathology / Q000523:psychology; D010465:Perception / Q000502:physiology*; D009435:Synaptic Transmission
chemical_list: D004298:Dopamine